Polish medtech company Medicalgorithmics, listed on the Warsaw Stock Exchange (GPW), has signed a partnership agreement with TeleNurse Plus, a leading innovator in telemedicine and one of the largest distributors of telehealth equipment in Greece. The agreement will make Medicalgorithmics’ latest products available in the Greek market, including the DRP platform featuring DRAI algorithms, recognized as a cutting-edge solution in the DRAI Martini study involving 14,000 patients and recently published in the prestigious journal Nature Medicine.
Telemedicine’s Critical Role in Greece
Greece’s unique geographical landscape, with its many islands and mountainous regions, presents significant challenges for healthcare access. Outside of Athens, hospital availability ranks among the worst in the EU, with 15 regions classified among the 97 most underserved healthcare areas in the European Union. In these regions, over half the population lacks nearby hospital access, making telemedicine—particularly telecardiology—a necessity rather than a convenience. As a result, demand for remote diagnostics and treatment is steadily growing.
“As part of our growth strategy, we’re expanding into promising markets and signing new agreements. This allows us to introduce new generations of our innovative products into key regions. The recent publication of the DRAI Martini study in Nature Medicine has significantly boosted interest in our technologies. We aim to fully capitalize on our growing brand recognition and are pleased to see increasing trust in Medicalgorithmics and the breakthrough solutions we offer,”
said Jarosław Jerzakowski, Chief Operating and Sales Officer at Medicalgorithmics.
Expanding Global Reach
With Greece, Medicalgorithmics’ solutions are now available in 24 countries worldwide. The company currently operates in:
- North America: USA, Canada
- Asia-Pacific and MENA: Australia, India, Philippines, Indonesia, Bahrain, Kuwait, Oman, UAE
- Europe: Poland, Czech Republic, Slovakia, Slovenia, Austria, Switzerland, Italy, Denmark, Finland, Sweden, UK, Armenia, Georgia, Turkey
Medicalgorithmics’ innovative software is also being used in clinical trials across the USA, Canada, UK, Poland, Czech Republic, Germany, Netherlands, Denmark, Norway, France, Italy, Greece, and Sweden.
The company plans to expand its involvement in clinical research, recently deepening its collaboration with Canada’s Population Health Research Institute (PHRI)—one of the world’s leading clinical research centers—at the start of February.
Source: ManagerPlus.pl
